Xconomy National

Archives

by in

Entry	Author	Date	Location
The Year in Seattle Biotech: Lots of Acquisitions, Few New Startups	Luke Timmerman	12/22/11	Seattle
NanoBio, Merck to Collaborate on Gates-Funded RSV Vaccine	Sarah Schmid	12/09/11	Detroit
PATH CEO Chris Elias Resigns For Top Anti-Poverty Job at Gates Foundation	Luke Timmerman	10/31/11	Seattle
Sloan-Kettering Spinoff Adjuvance Gains Traction For Vaccine Tech	Arlene Weintraub	10/27/11	New York
BIND and Selecta Pull in $50M from Russian Fund Seeking to Advance Nano-Drugs	Arlene Weintraub	10/27/11	Boston
BIO Investor Forum Roundup: Immune Design, Sorbent Therapeutics, Epizyme	Luke Timmerman	10/26/11	National
Amgen Cuts 70 Washington Jobs, Hutch Spins Off Blaze Bioscience, Henney Enters the Hall, & More Seattle-Area Life Sciences News	Luke Timmerman	10/20/11	Seattle
GSK Malaria Vaccine Stands Out at Gates Foundation Confab, But Cost Still the Big Question	Luke Timmerman	10/19/11	Seattle
Agenus Rejoices Over Positive Trial of Partner Glaxo’s Malaria Vaccine	Arlene Weintraub	10/18/11	Boston
Greenpeace and Michele Bachmann’s Joint Campaign to Stop Science	Tom Ranken	10/13/11	Seattle
Immune Design Rakes In Another $11M From Prior VC Round	Luke Timmerman	10/05/11	Seattle
Oncothyreon CEO Bob Kirkman Takes Leave, Chairman Chris Henney to Fill In	Luke Timmerman	09/08/11	Seattle
Theraclone Nabs Industry Award, Scopes Out Extra $10M Financing	Luke Timmerman	09/06/11	Seattle
Jennerex Shows that Unorthodox Cancer-Fighting Virus Can be Delivered the Usual Way	Luke Timmerman	08/31/11	San Francisco
Seattle Genetics’ Market Debut, Pathway Gets Bought, Theraclone’s Latest Trick Against HIV, & More Seattle-Area Life Sciences News	Luke Timmerman	08/25/11	Seattle
Consortium Find New HIV Antibodies, Zogenix Gets Drug to Clinical End Point, TrovaGene Reclaims Technology, & More San Diego Life Sciences News	Bruce V. Bigelow	08/18/11	San Diego
Scientists Spot New Antibodies Against HIV, Opening Up Potential Path to AIDS Vaccine	Luke Timmerman	08/17/11	National
IDRI Adds Dealmaker	Luke Timmerman	08/03/11	Seattle
There is a New Clinical Trial of a Novel Drug for African Sleeping Sickness. Who Cares?	Melinda Moree	07/12/11	National
Tachi Yamada, Former Gates Foundation Leader, Joins Frazier for New VC Gig	Luke Timmerman	06/27/11	Seattle
Merck’s Julie Gerberding, Former CDC Director, on the Future of Vaccines	Luke Timmerman	06/24/11	National
PATH Partners With GSK on Malaria Vaccine	Luke Timmerman	06/06/11	Seattle
Geospiza Sells to PerkinElmer, PATH Vaccine Nabs $100M, Halosource Gets China Approval, & More Seattle-Area Life Sciences News	Luke Timmerman	05/12/11	Seattle
PATH Meningitis Vaccine Gets $100M	Luke Timmerman	05/11/11	Seattle
Gates Foundation Dishes Out Latest $100K Grants for ‘Out of the Box’ Global Health Ideas	Luke Timmerman	04/28/11	Seattle
Immune Design Gets New CEO, Seattle Biomed Nabs $9M, VCs Turn Up Heat on FDA, & More Seattle-Area Life Sciences News	Luke Timmerman	04/28/11	Seattle
Seattle Biomed Nabs $9M Gates Foundation Grant to Speed Up Malaria Vaccine Effort	Luke Timmerman	04/27/11	Seattle
Immune Design, Developer of New Vaccines, Adds Former Elan President as New CEO	Luke Timmerman	04/27/11	Seattle
From Three-Month Ice to Fast Broadband Everywhere: Some Projects You Might Not Know About From Intellectual Ventures Lab	Curt Woodward	04/21/11	Seattle
NanoBio and U-M To Develop Vaccine Against Urinary Tract Infections	Thomas Lee	04/20/11	Detroit
Page 1 of 7	next page »